Home/Filings/4/0001213900-21-063363
4//SEC Filing

Paramore Miriam J 4

Accession 0001213900-21-063363

CIK 0001448431other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:45 PM ET

Size

8.3 KB

Accession

0001213900-21-063363

Insider Transaction Report

Form 4
Period: 2021-12-02
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-02$7.51/sh+3,558$26,72174,607 total
  • Exercise/Conversion

    Stock Option

    2021-12-02$7.51/sh3,558$26,72190,760 total
    Exercise: $7.51From: 2020-12-31Exp: 2025-03-11Common Stock (3,558 underlying)
  • Sale

    Common Stock Pursuant to 10B5-1 Plan

    2021-12-02$61.48/sh3,558$218,74671,049 total
Footnotes (1)
  • [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001713156

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:45 PM ET
Size
8.3 KB